Advertisement

Topics

Search Results for "Ncs Diagnostics Inc Canada"

04:45 EST 12th February 2016 | BioPortfolio

Matching Channels

Hepatitis B Immune Globulin Cangene

HepaGam B® [Hepatitis B Immune Globulin (Human) Injection] contains purified antibodies specific for the hepatitis B surface antigen (HBsAg). * It is approved in Canada and the United States f...

Alto Marketing - specialist healthcare and life science communications consultancy

Alto Marketing is a committed and forward-thinking specialist healthcare and life science communications consultancy.  With extensive experience of worldwide marketing in sectors including (...

Siemens

Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Cambridge

In addition to the world famous Cambridge University, Cambridge and its surrounding area is a hub of globally reaching biotechnology companies. With more than 247 companies, and the high quality res...

Glybera

uniQure has developed Glybera as a therapy for patients with the genetic disorder lipoprotein lipase deficiency. LPLD is an orphan disease for which no treatment exists today. The disease is caused ...

Matching News

Canada OKs febrile respiratory infection Dx test from RPS Diagnostics

A medical device license was granted by Health Canada to RPS Diagnostics' FebriDx test for detecting acute febrile respirator -More- 

Clinical Diagnostics Market in APAC - Market Analysis 2015-2019

About clinical diagnostics Clinical diagnostics or in-vitro diagnostics is a method to perform diagnostics tests by using instruments, assay reagents, and systems to diagnose a disease or medical cond...

Register for the 2015 BIO IP & Diagnostics Symposium!

The Third Annual BIO IP & Diagnostics Symposium takes place on September 18, 2015 in Alexandria, Virginia! Have you reserved your seat at the Symposium yet? Space is limited. Register today. The ...

BioMark Diagnostics Receives Clearance From Health Canada to Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer

VANCOUVER, British Columbia, Sept. 9, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces receipt of a No Objection Letter from Health Canada, cl...

Servier Canada gets rights to four of Spectrum's cancer therapies

Continuing on the path to focus on its core projects, Spectrum Pharmaceuticals Inc. granted Servier Canada Inc. exclusive rights to develop and sell four of its cancer products in Canada. All have bee...

In the news: Zymeworks, Genome Canada and Innovative Medicines Canada – Ep. 4.0

On this week’s show, Biotechnology Focus reporter Shawn Lawrence discusses Zymeworks $61.5M financing round and merger with CDRD spin-out Kairos Therapeutics, Genome Canada’s announcement of a...

Amoy Diagnostics, Illumina Team Up to Discover Next-Gen Sequencing Cancer Diagnostics in China

Amoy Diagnostics and Illumina Enter Strategic Collaboration for Next-Generation Sequencing Cancer Diagnostics in China XIAMEN, China & SAN DIEGO--(BUSINESS WIRE)--Amoy Diagnostics Co. Ltd. (ADx) and I...

Amoy Diagnostics, Illumina Team Up to Discover Next-Gen Sequencing Cancer Diagnostics in China

Amoy Diagnostics and Illumina Enter Strategic Collaboration for Next-Generation Sequencing Cancer Diagnostics in China XIAMEN, China & SAN DIEGO--(BUSINESS WIRE)--Amoy Diagnostics Co. Ltd. (ADx) and I...

Matching PubMed Articles

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement